Albert Jude Manifold - 03 Mar 2025 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Mar 2025, 16:30:22 UTC
Prior SEC filing
04 Mar 2025
Next SEC filing
27 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Neil Colgan, Attorney-in-fact for Albert Jude Manifold

Key filing fact

Albert Jude Manifold filed Form 4 for CRH PUBLIC LTD CO (CRH) on 05 Mar 2025.

Key facts

  • This page summarizes Albert Jude Manifold's Form 4 filing for CRH PUBLIC LTD CO (CRH).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Mar 2025, 16:30.

Change

  • Previous filing in this sequence was filed on 04 Mar 2025.
  • Current net transaction value: -$11,985,461.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRH transaction

Ordinary Shares

Award

Transaction value
$0
Shares
+197,993
Change %
+247%
Price
$0.000000
Shares after
278,076
Date
03 Mar 2025
Ownership
Direct
Footnotes
F1
CRH transaction

Ordinary Shares

Options Exercise

Transaction value
$0
Shares
+25,942
Change %
+9.3%
Price
$0.000000
Shares after
304,018
Date
03 Mar 2025
Ownership
Direct
Footnotes
F2
CRH transaction

Ordinary Shares

Tax liability

Transaction value
$11,985,461
Shares
-116,446
Change %
-38%
Price
$102.93
Shares after
187,572
Date
03 Mar 2025
Ownership
Direct
Footnotes
F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Albert Jude Manifold is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

Reflects the vesting and release of awards granted in 2020 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 25,484 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee").

Footnote F2

Reflects the vesting and release of a 2022 time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 25,942 shares vested on March 3, 2025, including the award of 2,172 additional Ordinary Shares as dividend equivalents.

Footnote F3

Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in connection with the aforementioned award.

Footnote F4

The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $102.30 and $103.535 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request.

Footnote F5

The Reporting Person retired from his position as Chief Executive Officer and as a member of the Board of Directors of the Issuer, effective December 31, 2024, and therefore a Form 3 was not filed in connection with the Issuer's transition to U.S. domestic issuer reporting status, effective January 1, 2025.

SEC remarks

Former Executive Officer & Director

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .